Continuous Flow Left Ventricular Assist Device Outcomes in Commercial Use Compared With the Prior Clinical Trial
- 1 October 2011
- journal article
- research article
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 92 (4) , 1406-1413
- https://doi.org/10.1016/j.athoracsur.2011.05.080
Abstract
No abstract availableThis publication has 24 references indexed in Scilit:
- Heart Transplant vs Left Ventricular Assist Device in Heart Transplant-Eligible PatientsThe Annals of Thoracic Surgery, 2011
- Results of the Post-U.S. Food and Drug Administration-Approval Study With a Continuous Flow Left Ventricular Assist Device as a Bridge to Heart TransplantationJournal of the American College of Cardiology, 2011
- The Development of Aortic Insufficiency in Left Ventricular Assist Device-Supported PatientsCirculation: Heart Failure, 2010
- Aortic valve pathophysiology during left ventricular assist device supportThe Journal of Heart and Lung Transplantation, 2010
- Continuous-flow LVAD improves quality of lifeNature Reviews Cardiology, 2010
- Transcutaneous Energy Transmission for Mechanical Circulatory Support Systems: History, Current Status, and Future ProspectsJournal of Cardiac Surgery, 2010
- Advanced Heart Failure Treated with Continuous-Flow Left Ventricular Assist DeviceNew England Journal of Medicine, 2009
- Rise of the Machines — Left Ventricular Assist Devices as Permanent Therapy for Advanced Heart FailureNew England Journal of Medicine, 2009
- Use of a Continuous-Flow Device in Patients Awaiting Heart TransplantationNew England Journal of Medicine, 2007
- Gastrointestinal bleeding from arteriovenous malformations in patients supported by the Jarvik 2000 axial-flow left ventricular assist deviceThe Journal of Heart and Lung Transplantation, 2005